To facilitate the CTD-ILD early diagnosis, we discovered that the combination of MMP-2, MMP-7, MMP-9, MMP-10, MMP-12, and TIMP-1 can characterize reliably RA-ILD+ patients versus those RA patients without ILD. Here, MMP9 is linked to rheumatoid arthritis.